跳到正文
MarketHOT
English
摘要
SEC · EDGAR 财务披露·· 12 天前AI 评分18

IceCure Medical 获中国新专利,扩大全球知识产权组合

6-K - IceCure Medical Ltd. (0001584371) (Filer)

AI 导读

IceCure Medical 于 2026 年 11 月 9 日发布消息称,其冷冻系统连接器在中国获授新专利,扩展了公司的全球知识产权组合。公司将该新闻稿作为 Form 6-K 的附件提交给 SEC;这份文件是外国私人发行人报告。

正文

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2026 (Report No. 3)

Commission File Number: 001-40753

ICECURE MEDICAL LTD.

(Translation of registrant’s name into English)

7 Ha’Eshel St., PO Box 3163

Caesarea, 3079504 Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

CONTENTS

On November 9, 2026, IceCure Medical Ltd. (the “Company”) issued a press release titled “IceCure Granted New Patent in China for Its Cryogenic System Connector, Expanding Its Global IP Portfolio”, a copy of which is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.

This Report of Foreign Private Issuer on Form6-Kis incorporated by reference into the Company’s Registration Statements on Form F-3 (File Nos. 333-297030, 333-290046 and 333-258660) and Form S-8 (333-298361, 333-270982, 333-264578, 333-262620 and 333-281587), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report of Foreign Private Issuer on Form6-Kis submitted, to the extent not superseded by documents or reports subsequently filed or furnished

1 

EXHIBIT INDEX

Exhibit No.    
99.1   Press Release issued by IceCure Medical Ltd., dated November 9, 2026, titled “IceCure Granted New Patent in China for Its Cryogenic System Connector, Expanding Its Global IP Portfolio.”

2 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  IceCure Medical Ltd.
     
Date: November 9, 2026 By: /s/ Eyal Shamir
    Name:  Eyal Shamir
    Title:    Chief Executive Officer

3 

来源:SEC EDGAR · 本站存档